354 related articles for article (PubMed ID: 20931348)
21. Guidelines for controlled trials of drugs in tension-type headache: second edition.
Bendtsen L; Bigal ME; Cerbo R; Diener HC; Holroyd K; Lampl C; Mitsikostas DD; Steiner TJ; Tfelt-Hansen P;
Cephalalgia; 2010 Jan; 30(1):1-16. PubMed ID: 19614696
[TBL] [Abstract][Full Text] [Related]
22. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
[TBL] [Abstract][Full Text] [Related]
23. Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults.
Tassorelli C; Diener HC; Dodick DW; Silberstein SD; Lipton RB; Ashina M; Becker WJ; Ferrari MD; Goadsby PJ; Pozo-Rosich P; Wang SJ;
Cephalalgia; 2018 Apr; 38(5):815-832. PubMed ID: 29504482
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
Schreiber CP; Cady RK
Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
[TBL] [Abstract][Full Text] [Related]
25. Acupuncture for the prevention of episodic migraine.
Linde K; Allais G; Brinkhaus B; Fei Y; Mehring M; Vertosick EA; Vickers A; White AR
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD001218. PubMed ID: 27351677
[TBL] [Abstract][Full Text] [Related]
26. [Therapeutic guidelines for headache].
Nappi G; Cavallini A
Ital J Neurol Sci; 1995 Nov; 16(8 Suppl):29-34. PubMed ID: 8751186
[TBL] [Abstract][Full Text] [Related]
27. Methodological quality of randomized controlled trials of spinal manipulation and mobilization in tension-type headache, migraine, and cervicogenic headache.
Fernández-de-las-Peñas C; Alonso-Blanco C; San-Roman J; Miangolarra-Page JC
J Orthop Sports Phys Ther; 2006 Mar; 36(3):160-9. PubMed ID: 16596892
[TBL] [Abstract][Full Text] [Related]
28. Topiramate in Migraine Prevention: A 2016 Perspective.
Silberstein SD
Headache; 2017 Jan; 57(1):165-178. PubMed ID: 27902848
[TBL] [Abstract][Full Text] [Related]
29. Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults.
Diener HC; Tassorelli C; Dodick DW; Silberstein SD; Lipton RB; Ashina M; Becker WJ; Ferrari MD; Goadsby PJ; Pozo-Rosich P; Wang SJ; Houle TT; Hoek TCVD; Martinelli D; Terwindt GM;
Cephalalgia; 2020 Sep; 40(10):1026-1044. PubMed ID: 32722936
[TBL] [Abstract][Full Text] [Related]
30. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.
Ferrari MD; Goadsby PJ; Roon KI; Lipton RB
Cephalalgia; 2002 Oct; 22(8):633-58. PubMed ID: 12383060
[TBL] [Abstract][Full Text] [Related]
31. Chronic daily headache: correlation between the 2004 and the 1988 International Headache Society diagnostic criteria.
Bigal ME; Tepper SJ; Sheftell FD; Rapoport AM; Lipton RB
Headache; 2004; 44(7):684-91. PubMed ID: 15209691
[TBL] [Abstract][Full Text] [Related]
32. WITHDRAWN: Oral sumatriptan for acute migraine.
McCrory DC; Gray RN
Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD002915. PubMed ID: 22336784
[TBL] [Abstract][Full Text] [Related]
33. Oral sumatriptan for acute migraine.
McCrory DC; Gray RN
Cochrane Database Syst Rev; 2003; (3):CD002915. PubMed ID: 12917936
[TBL] [Abstract][Full Text] [Related]
34. Magnesium in Migraine Prophylaxis-Is There an Evidence-Based Rationale? A Systematic Review.
von Luckner A; Riederer F
Headache; 2018 Feb; 58(2):199-209. PubMed ID: 29131326
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of low-dose ibuprofen in acute migraine treatment: systematic review and meta-analysis.
Suthisisang C; Poolsup N; Kittikulsuth W; Pudchakan P; Wiwatpanich P
Ann Pharmacother; 2007 Nov; 41(11):1782-91. PubMed ID: 17878396
[TBL] [Abstract][Full Text] [Related]
36. Guidelines Update: Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition - An experience-based update.
Abu-Arafeh I; Hershey AD; Diener HC; Tassorelli C
Cephalalgia; 2023 May; 43(5):3331024231178239. PubMed ID: 37226450
[TBL] [Abstract][Full Text] [Related]
37. Migraine without aura and migrainous disorder in children; International Headache Society (IHS) and revised IHS criteria.
Cano A; Palomeras E; Alfonso S; Ortega D; Sanz P; Fossas P
Cephalalgia; 2000 Sep; 20(7):617-20. PubMed ID: 11128818
[TBL] [Abstract][Full Text] [Related]
38. Migraine treatment in developmental age: guidelines update.
Papetti L; Spalice A; Nicita F; Paolino MC; Castaldo R; Iannetti P; Villa MP; Parisi P
J Headache Pain; 2010 Jun; 11(3):267-76. PubMed ID: 20349201
[TBL] [Abstract][Full Text] [Related]
39. Medical Treatment Guidelines for Acute Migraine Attacks.
Hsu YC; Lin KC; Taiwan Headache Society TGSOTHS
Acta Neurol Taiwan; 2017 Jun; 26(2):78-96. PubMed ID: 29250761
[TBL] [Abstract][Full Text] [Related]
40. A meta-analysis of the placebo response in acute migraine and how this response may be influenced by some of the characteristics of clinical trials.
Macedo A; Farré M; Baños JE
Eur J Clin Pharmacol; 2006 Mar; 62(3):161-72. PubMed ID: 16402240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
